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I, as a corresponding author, regret to withdraw our paper entitled "Specific nephrotoxicity and cardiotoxicity of BT-Cal ® , Sigma Anti-bonding Molecule Calcium Carbonate, in mice", which was published in the Laboratory Animal Research 2013; 29(1): 7-11.
The reason why we withdraw the paper is a controversy on the interpretation of the results, because the institution performed the study (Laboratory Animal Research Center, Chungbuk National University, Korea) is not an organization approved for Good Laboratory Practice (GLP), and the study was not performed according to the GLP's Standard of Procedures.
Our research group and the manufacturer of the material (BT-Cal ® ) are planning to perform additional study in a GLP organization. Therefore, it is expected that we can resubmit a manuscript in the future. 
